Product Information
FENOFIBRATE 145 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1198 per EA under NDC 69097045805. Its NADAC has been published 485 times since Mar 15, 2017.
Strength
145 mg/1
Manufacturer
Cipla USA Inc.NDC
69097045805
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA208709On Market Since
12/15/2016
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 145 MG TABLET has been published 485 times since Mar 15, 2017, and over the history we have for it it has declined 81.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1198 per EA |
|---|---|
| All-time high | $0.6452 (Mar 15, 2017) |
| All-time low | $0.1088 (Nov 20, 2024) |
| 52-week high | $0.1348 |
| 52-week low | $0.1130 |
| Median price | $0.1879 |
| Average price | $0.2210 |
| Largest weekly change | +29.9% (Sep 23, 2020) |
| Weeks tracked | 485 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 145 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 145 MG TABLET, manufactured by Cipla USA Inc., is $0.1198 per EA (NDC 69097045805), effective Jun 24, 2026.
How has the price of FENOFIBRATE 145 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 145 MG TABLET has declined 81.4%. It has been tracked across 485 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 145 MG TABLET?
Since Mar 15, 2017, the NADAC for FENOFIBRATE 145 MG TABLET has ranged from a low of $0.1088 (Nov 20, 2024) to a high of $0.6452 (Mar 15, 2017), with a median of $0.1879 per EA.
Are there cheaper alternatives to FENOFIBRATE 145 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as FENOFIBRATE 145 MG TABLET, but none are currently priced below it.
Who manufactures FENOFIBRATE 145 MG TABLET?
FENOFIBRATE 145 MG TABLET (NDC 69097045805) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification